Two of the biggest challenges in medicine today are the need to detect diseases in a non-invasive manner, and to differentiate between patients using a single diagnostic tool. The current study targets these two challenges by developing a molecularlymodified Silicon Nanowire Field Effect Transistors (SiNW FETs) and showing its use in the detection and classification of many disease breathprints (lung cancer, gastric cancer, asthma and Chronic Obstructive Pulmonary Disease). The fabricated SiNW FETs are characterized and optimized based on a training set that correlated their sensitivity and selectivity towards volatile organic compounds (VOCs) linked with diseased states. The best sensors obtained in the training set are then examined under real-world clinical conditions, using breath samples from 374 subjects.
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Abstract:
Two of the biggest challenges in medicine today are the need to detect diseases in a non-invasive manner, and to differentiate between patients using a single diagnostic tool. The current study targets these two challenges by developing a molecularlymodified Silicon Nanowire Field Effect Transistors (SiNW FETs) and showing its use in the detection and classification of many disease breathprints (lung cancer, gastric cancer, asthma and Chronic Obstructive Pulmonary Disease). The fabricated SiNW FETs are characterized and optimized based on a training set that correlated their sensitivity and selectivity towards volatile organic compounds (VOCs) linked with diseased states. The best sensors obtained in the training set are then examined under real-world clinical conditions, using breath samples from 374 subjects.
Analysis of the clinical samples showed that the optimized SiNW FETs can detect
and discriminate between almost all binary comparisons of the diseases under examination with >80% accuracy. Overall, this approach has the potential to support detection of many diseases in a direct positive way, which can reassure patients and prevent numerous negative investigations.
When not in contact with the analyte, the sensor should return to its baseline state rapidly, or be simple and inexpensive so that one could manufacture large numbers of disposable units.
We have developed Silicon Nanowire Field Effect Transistors (SiNW FETs) [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] as the sensing matrices for the detection and discrimination between disease breathprints. As representative diseases, we chose gastric cancer (GC), lung cancer (LC), asthma and Chronic Obstructive Pulmonary Disease (COPD). NOTE: For this study, the asthma and COPD are considered as a control group for LC, and is abbreviated as "AC" henceforth. These diseases cover both the direct and quasidirect track to the breath. 4, 16 Indeed, GC-related VOCs might reach the breath directly through the esophagus or from the lung alveoli. While LC-and AC-related VOCs reach the breath either by release directly into the airways or by diffusion in alveoli.
The SiNW FETs are characterized and optimized based on a training set that 
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Testing the sensors exposed to simulants of disease breathprints
In the second phase of the study, the molecularly-modified SiNW FET sensors were exposed to a number of VOCs presumed as breathprint biomarkers for the chosen diseases: GC, LC and AC ( Table 2) . The presumed VOCs linked with GC conditions via breathprint are: 2-propenenitrile, furfural, 6-methyl-5-hepten-2-one.
14, 31 The presumed VOC linked with AC conditions by breathprint is pentane. 31 The presumed
VOCs linked with LC conditions by breathprint are: heptane, decane, 2-methylpentane, 2-ethyl-1-hexanol, propanal, pentanal and acetone. 31 Each SiNW FET was exposed to 4 concentrations of each VOC, and each exposure was repeated 3 times. In each exposure to VOC, the source-drain current (I ds ) vs. back gate voltage (V gs ) characteristic curve was obtained by sweeping the gate voltage between +40V and -40V (Figure 2a) . For the sake of reference, I ds -V gs curves were obtained in vacuum before and after exposure to the VOC (Figure 2a ). 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 carriers moving under the influence of the electrical field), and the I ds @ different V gs values. The extraction and calculation of these features is described in the Experimental Methods section. As these features change with exposure, their values (which can be monitored and recorded during the experiment) may be informative.
For example, the V th values decrease on exposure to 2-propenenitrile from -27 to -29.5V (Figure 2b) at the time the µ h values increase from 125 to 140 cm 2 /Vs (Figure 2c) , and the I ds @ V gs =-30V values decrease slightly from 120 to 80 µA (Figure 2d ). In the representative example (Figure 2e) , repeated exposure cycles on the same sensor are usually characterized by a relatively stable baseline and an almost repeatable sensing features from cycle to cycle (±3% variance).
The detection limit of the sensors to each VOC as well as the concentrations found in breath can be found in the Supporting Information ( Table S1 ). The detection limit of each sensor is different and depends on the VOC's structure. In this context, it is important to clarify that the SiNW FET sensors do not obey the lock-and-key sensing approach. 18, 31 Instead, they have affinity to multiple VOCs and, therefore, the sensing signal on exposure to a mixture of VOCs (e.g., a breath sample) reflects the fingerprint of all the VOCs in it. Under these circumstances, different molecular modifications of the SiNW change the affinity balance between the different VOCs found in a specific mixture. Therefore, even if the detection limit of specific SiNW FET to a certain VOC is higher than its concentration in the breath, the SiNW FET can still detect the change in breath sample composition, as the overall change (sum) of VOC changes in the breath due to disease state is in the range of a few to 10s of ppm.
These SiNW FETs have a very wide dynamic range between their limit of detection ( Separation of GC-related VOCs from AC biomarkers was called "Test-A"; separation of LC-related VOCs from AC-related VOCs was Test-B"; and separation between LC-and GC-related VOCs was "Test-C". In Test-A and Test-B, the cancer group was considered the "positive" group, whereas AC was considered the "negative"
group. In Test-C, LC was considered the "positive" group and GC was considered "negative". The success in classification of the ANN analysis in each test is presented in Figure 3 . The ANN model calculated values of sensitivity, specificity and accuracy of each comparison, the method being found in the Experimental Methods section.
Results from the vast majority of the sensors (Figure 3) , and in most comparisons, were satisfactory (>80% accuracy). Besides this accuracy for the classification, a few important findings were recorded. In Test-A, most sensors correctly classified 100%
of the cases, irrespective of the vapor pressure values of the VOCs. In Test-B, S4
had a similar classification ability to S2 and S3 for LC (~100% accuracy) and gave slightly better classification than S1, S5 and S6. On the other hand, S1 showed the highest classification ability of AC samples (100%). In Test-C, S1 again gave the highest percentage of correct classification; 93% for LC-related VOCs and 85% for GC-related VOCs, resulting in 92% accuracy.
Validation of the sensors in a clinical study
To validate the performance of the SiNW FETs under lab conditions using simulants of breathprint-related VOCs, clinical trials were carried out with the same sensors (Experimental Methods section); the design of the clinical study is shown in Figure 4 .
Briefly, breath samples were collected from 374 volunteers belonging to 4 groups:
control subjects not suffering from any of the conditions tested (n=129), LC patients (n=149), GC patients (n=40) and AC patients (n=56). Cancer patients were also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 section. Using one or both of these approaches, the aim was to distinguish between breathprints of patients belonging to the 4 study groups (Figure 4) .
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Age ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 value in the blue box is the specificity and in the green box is the accuracy. NOTE: In comparing any of the groups with the "control" group, the latter was clearly considered the "negative" group, while the others were considered the "positive" groups. In comparing one of the cancer groups (LC or GC) to AC, former was considered the "positive" and AC the "negative" group. Finally, in comparing the 2 types of cancer, LC was taken as the "positive" group, and GC the "negative" group. The values of the comparisons are reviewed in Supporting Information Table S3 . Figure 5 presents the sensitivity, specificity and accuracy values as determined by ANN analysis for binary comparisons between breathprint of volunteers from all groups. Most sensors had an acceptable ability to classify the different diseases, distinguishing them from the control samples. S1, S3 and S5 have the highest ability of to classify correctly breathprints. In trying to separate the LC from the control group, S1 was the most suitable sensor, with sensitivity, specificity and accuracy all >80% (sensitivity 87%, specificity 82% and accuracy 84%). In trying to separate GC patients from the control group, S3 had greater sensitivity than S1, sensitivity 87%, specificity 98%, and accuracy 95%. Regarding AC, when the goal was to rule in a subject (meaning the patient was most likely sick and the test being used as confirmation), the sensor of choice was S1 (specificity 81%). When the goal was to rule out a patient, the sensor of choice was S5 (sensitivity 75%). Regarding the separation of LC patients from AC patients (cancer vs. non-cancer), S1 discriminated best overall (sensitivity 92%; specificity 80%; and overall accuracy 89%) -making it an excellent sensor for ruling out diagnostic decision. Examining the discrimination between GC and AC, most sensors showed noteworthy results (accuracy >80%). Nevertheless, S5 gave the best results, with all 3 statistical parameters >91%, with an especially high sensitivity of 98%. Comparing GC and LC patients, S1 gave the best results, offering extremely high values of sensitivity, specificity and accuracy (97, 90, and 96%, respectively). Looking at the separation ability of all the sensors in the case of AC vs. control, the performance of the sensors was rather low across the board. This could have been to only one VOC (pentane) characterizing these diseases (asthma and COPD; cf. Table 2 ) rather than a pattern of VOC, as in the other diseases. Adsorption of a combination of VOCs on the surface of the Si NW sensor led to a higher signal-to-noise ratio.
The performance of our devices under real-world conditions has several advantages over the current gold standard test. For example, the National Lung Screening Trial found that CT scans were highly sensitive in detecting lung cancer in smokers compared with chest x-rays, but they were not very specific in ruling out 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 malignancy. 52 Sensitivity was 94% and specificity 73% for lung cancer detection with CT compared with 74% and 91% with chest x-rays in the first round of screening of high-risk smokers and former smokers included in the trial. 52 This combination led to substantially more positives in the CT group (27 vs. 9%), nearly all of which prompted follow-up diagnostic procedures. 52 In comparison, the diagnostic performance of S1
provided a benefit in being more cost efficient, practical, and efficacious. In another example, upper endoscopy with a full biopsy is the gold standard for diagnosing and screening gastric cancer and the related precancerous lesions. 53 However, this is not a feasible screening approach outside Asia and the cost-effectiveness in other this parts of the world has not been assessed. The cost-effectiveness of our sensors would thus be more affordable and give greater compliance for an at-risk population.
On the other hand, an acceptable non-invasive test with high diagnostic performances is lacking, since the best available test -detection of pepsinogens in blood -fails to reach the expected accuracy levels -it could be missing in the majority of cancer cases. 53 Whilst in population-based screening settings, the sensitivity of pepsinogen tests is 67-85% and the specificity 76-87% for the detection of atrophy, the sensitivity of gastric cancer detection is only 37-62%. 53 In comparison to these values, S3, for example, is the frontrunner for clinical use as populationbased diagnostic or screening tool.
To further validate the analysis, the same binary comparisons were carried by discriminant function analysis (DFA). The data were similar to the ANN results, with S1 being the most adequate sensor for disease classification in most cases, coupled with S3 and S4 for the remaining classifications (LC vs. control and LC vs. AC).
Results of the DFA analysis are given in Supporting Information, Figure S1 and Table S4 . It is worthy to point out that looking at the DFA results ( Figure S1 ), we get a different picture than received in using ANN. In the case of DFA, it is S3 that has the best results for discriminating between GC and the other two diseases, resulting in an accuracy of 95%. When comparing GC with the control group, we get an accuracy of 93%, which is very high, but S4 showed better results (accuracy of 94%) due to a higher sensitivity. When studying the differentiation of LC from the control group, we can see that a combination of S3 and S4 should be used, as S3 has a high value of specificity (87%), and S4 has a high sensitivity value (90%). Therefore, S3
should be used as a ruling in tool, while S4 would be used for ruling out. Separating the cancerous lung conditions from the non-cancerous lung conditions (AC), S4 is the most suitable sensor as it has extremely high values of sensitivity, specificity and accuracy (89% sensitivity, 75% specificity, and 86% accuracy). The last comparison to be made is the AC group and the control group. In this case, we can see low 54 The best results were achieved in the DFA model built by using features extracted from S4 for both LC and GC staging ( Table 4) . During the development of the staging models, early stages were considered to be the positive group and the advanced stages negative, which means that the sensitivity indicates detection at the early stage, whereas the specificity is related to advanced stage detection. Classification o the results in the staging analysis by DFA are shown in Figure 6 . In interpreting this data, DFA classification gave an accuracy of 81% for LC staging and 87% for GC staging. In LC staging, the sensitivity value was low (34.5%), most likely due to the difference in the size of the groups (n=34 for early stage patients and n=110 for the advanced stage). Indeed, big differences in the group size leads to the result being biased towards the larger group, leading to a lack of sensitivity. 55 Despite low sensitivity, the specificity achieved by S4 was very high (95%), being the highest accuracy value. Regarding the GC staging results, S4
showed an equally high ability in identifying both early and advanced stages of the disease (86.5% of the samples were correctly classified; 84.6% of the early stage;
and 87.5% of the advanced stage). The AUC values of the classification achieved by S4 were calculated as 0.68 for LC staging and 0.87 for GC staging. ROC curves developed for the separation of each stage from the negative samples can be found in Supporting Information, Figure S2 . Clear differences were seen between each set of ROC curves (early vs. negative compared to advanced vs. negative) and the different diseases. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
Experimental Methods
Growth of the SiNWs
P-type silicon nanowires (SiNWs) were grown following the vapor liquid solid (VLS) principle using a cold-wall chemical vapor deposition (CVD) reactor. During the 30 min CVD process under a total pressure of 2 mbar, the flow rates of SiH 2 , B 2 H 6 (100 ppm in H 2 ), and Ar were kept constant at 4, 1, and 10 sccm, respectively, i.e. in a B to Si ratio of 1:20,000. Growth was catalyzed by commercially available Au colloids (British Biocell Int.) of 30 nm diameter. Growth substrate temperature was ~500°C.
The resulting SiNWs had an average diameter of 40±8nm and average length of 8.5±1.5 µm.
Deposition of the SiNWs array
The as-grown SiNWs were first immersed in a KI/I 2 /H 2 O solution (mass ratio 4:1:40) for 1 min to remove the gold catalyst used in the growing process, and any possible gold contaminants remaining on the surface of the SiNW. The Si NWs were etched using buffered hydrofluoric acid for 10 sec. Following this, the SiNWs were dispersed in ethanol using ultra-sonication for 5 sec, and were later deposited on a highlydoped (0.001 Ω·cm resistivity) P-type Silicon (100) substrate with 300 nm thermal oxide and a Ti/Au (10/200 nm) bottom gate electrode. Deposition was based on a spray-coating procedure, 56 which started with the deposition of the substrate on a hotplate set at 75°C. A SiNW suspension was applied with a spray gun (PRONA R2F) at a carrier gas pressure of 40 psi, and a tilt angle of (5º±2º) to the substrate.
The spray-coating process resulted in well-aligned nanowire arrays (density ~ 1 NW/ 100 µm 2 ).
Fabrication of SiNW FETs
The substrate coated with SiNWs was cleaned by successive immersions in acetone, methanol, and isopropanol, followed by 5 sec rinsing in buffered HF. The top source and drain electrodes (20 pairs of 20 nm Ti/ 160 nm Au interdigitated electrodes, length 1300 µm, width 2 µm, spacing 2 µm) were deposited by a photolithography (Karl Suss MA6 Mask aligner) and lift-off process on top of the SiNWs. Surface characterization of the fabricated used dark-field light microscopy to determine the density of SiNWs on the device, which were then observed in a scanning electron microscope (SEM) to assure proper contact between the SiNWs and the electrodes. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
Surface modification of the SiNW FETs
Surface modification of the SiNW FETs was carried as described before. 43 Briefly, following surface activation achieved by 30 sec of plasma treatment, the SiNW FET surfaces were modified with various molecules (listed in Table 1 ). SiNW FETs were modified using a single-step silane modification (SSM), a 2-step silane-chloride modification (TSCM), or a 2-step silane-monomer modification (TSMM). Devices 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Cancer Institute, Jacksonville, Florida, USA. A summary of the clinical data is presented (Figure 4b) .
In each location, the samples were collected in the same hospital room.
Patients were asked to fast, and withhold smoking and alcohol consumption for at least 2 h before sampling. The sorbent tubes were stored at 4ºC until transported to Laboratory of Nanomaterial Based Devices (Technion -Israel Institute of Technology, Haifa, Israel) for analysis. The duration between sample collection and analysis was <3 months (NOTE: breath VOCs can preserved in these sorbent tubes up to 6 months without change in their composition). The breath samples were collected following a previously described protocol . 14, 57 To reduce the effect of ambient contamination, a lung washout procedure was used. According to the protocol, the patient took regular, unexerted breaths for 3 min through a mouthpiece with a filter cartridge on the inspiratory port (Eco Medics, Duerten, Switzerland), thereby greatly reducing the concentration of ambient VOCs in the inspired air.
NOTE:
The subjects were asked to breathe normally throughout the entire procedure to avoid hyperventilation. Following lung washout, the subjects were asked to inhale normally once more through the filter and exhale normally through the mouthpiece 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 test chamber containing the SiNW FET sensors described in Table 1 
Artificial Neural Networks (ANNs)
ANNs is a machine-learning method inspired by neural networks in the human nervous system. It is based on a set of functions connecting the input (sensor features in this case) with the output (classification of samples to a specific disease).
This relationship is achieved by optimizing certain parameters -connection weights, and amount of neurons (calculation centers) -to achieve the best classification from the inputs available. To reach the final mathematical binary classifying models to distinguish between the 4 groups of participants (LC, GC, Asthma/COPD, and negative to all), a 2-phase calculation process was used. The same steps were carried out for every available database (one per sensor (6) and possible binary classifier (6); a total of 36 models). Initially, a feature selection (FS) procedure was used to determine the sensing features with the greatest discriminative power to identify correctly the samples within a particular dataset. FS calculation was based on the Relief-F algorithm, which is a filter FS method. It operates by locating the nearest neighbors of a sample in its same class and other classes, giving priority to those features that distinguish better the nearest neighbors from different classes.
58
FS leads to the location of the best suited variables (sensing features in this case) to fulfil a second modeling phase, which leads to a reduced computational load and improved performance of further models. 59 The second part of the calculation is the modeling phase; using the features given by the FS test as independent variables, a this research. 62 Second, the training function is in charge of the calculations that modify the weights. The one chosen here was the Levenberg-Marquardt (trainLM) function as it is the quickest algorithm for moderate-sized MLPs and has a memory reduction feature where the training dataset is large. 62 Third, the transfer function is in charge of introducing non-linearity in the calculations, as well as limiting the range of the values of the responses given by each neuron. The selected option was the sigmoid function, which limits the values between zero and one. 54 Finally, the Lc parameter is analogous to the learning coefficient in classic back-propagation algorith; 63 its value decreases and increases with Lcd and Lci, respectively, until the modifications of Lc create a worse statistical performance.
Discriminant Factor Analysis (DFA)
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